Targeted therapies: Ibrutinib: new option for relapsed MZL.
Lisa
L
Hutchinson
D000225:Adenine / Q000031:analogs & derivatives; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D009364:Neoplasm Recurrence, Local; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines
D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine